How is the sales going?

[anonymous]

Lonnel is saying inflection point 2nd half 2024. That will be because of hospital sales where the ideal patient for lexicon is. Transition from hospital to home.

- Do you think inpefa will succeed?
- How will the numbers look like before we sell into hospitals?
- Should we indeed count on an inflection point 2nd half 2024?
- when do you think they are aiming on a buy out? What kind of timeline?
- Do you think they need to raise capital again? Do you think they dilute again or will there be another scenario like non us sales partnership of inpefa with upfront payment or buy out in 2024?

 

[anonymous]

Inpefa has no value unless the payers cover it.
Resume updated!

 

[anonymous]

How is the grammars going?

 

[anonymous]

Managers are now pushing everyone to get a CarShield contract. Is this true?

 

[anonymous]

Managers are now pushing everyone to get a CarShield contract. Is this true?

What a rip off. They aggressively market their overpriced car warranty to uneducated car owners from lower socioeconomic backgrounds.

 

[anonymous]

How is the grammars going?

Pff - cheap person.

 

[anonymous]

Ghetto Pharma. The clock is ticking.

 

[anonymous]

WTF are you talking about? Is this BS code for something else? Just say it!!!

 

[anonymous]

WTF are you talking about? Is this BS code for something else? Just say it!!!

Lion

 

[anonymous]

Lonnel is saying inflection point 2nd half 2024. That will be because of hospital sales where the ideal patient for lexicon is. Transition from hospital to home.

- Do you think inpefa will succeed?
- How will the numbers look like before we sell into hospitals?
- Should we indeed count on an inflection point 2nd half 2024?
- when do you think they are aiming on a buy out? What kind of timeline?
- Do you think they need to raise capital again? Do you think they dilute again or will there be another scenario like non us sales partnership of inpefa with upfront payment or buy out in 2024?

Yeah, I think most new products take over a year after launch to start generating meaningful sales.

 

[anonymous]

Ghetto Pharma

 

[anonymous]

This is a message from an international investor trying to find out any information from the reps.

 

[anonymous]

This is a message from an international investor trying to find out any information from the reps.

buy buy buy! This thing is about to fly!

 

[anonymous]

Farxiga is going generic this year!

 

[anonymous]

Shit, this place is the biggest collection of meatheads I’ve ever come across.

 

[anonymous]

Inpefa has no chance. Farxiga already generic, cardiologists don’t trust SGLT2i’s, saturated market, no presence in the hospital, no advantage, no coverage by insurance, fifth to the market, anything else? So glad I turned this job down!

Lonnel is saying inflection point 2nd half 2024. That will be because of hospital sales where the ideal patient for lexicon is. Transition from hospital to home.

- Do you think inpefa will succeed?
- How will the numbers look like before we sell into hospitals?
- Should we indeed count on an inflection point 2nd half 2024?
- when do you think they are aiming on a buy out? What kind of timeline?
- Do you think they need to raise capital again? Do you think they dilute again or will there be another scenario like non us sales partnership of inpefa with upfront payment or buy out in 2024?

 

[anonymous]

Shit, this place is the biggest collection of meatheads I’ve ever come across.

So true. It’s a struggle so far this year for all of us and they hire someone with no sales to lead us. Makes no sense. Resume updated.

 

[anonymous]

So true. It’s a struggle so far this year for all of us and they hire someone with no sales to lead us. Makes no sense. Resume updated.

It’s a dumpster fire right now. Our new sales leader is in over her head. Next!

 

[anonymous]

It’s a dumpster fire right now. Our new sales leader is in over her head. Next!

So Inpefa is shit selling product?